SPRY icon

ARS Pharmaceuticals
SPRY

Overview Fund Trends Analyst Outlook Journalist POV

62 hedge funds and large institutions have $1.13B invested in ARS Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 62 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
62
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$405M
2
+$156M
3
+$117M
4
RCM
RA Capital Management
Massachusetts
+$80.7M
5
BC
Boxer Capital
California
+$77.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$405M
2
$156M
3
$117M
4
$80.7M
5
$77.6M
6
$54.4M
7
$23.2M
8
$19.8M
9
$18.1M
10
$15.8M
11
$13.9M
12
$11M
13
$9.99M
14
$9.72M
15
$9.27M
16
$8.72M
17
$8.07M
18
$7.69M
19
$6.95M
20
$6.4M
21
$5.96M
22
$5.79M
23
$5.38M
24
$5M
25
$4.5M
1
2 3